Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-232
Closed -$5.29K 1972
2023
Q1
$5.29K Buy
232
+199
+603% +$5.13K ﹤0.01% 1489
2022
Q4
$1.13K Hold
33
﹤0.01% 2097
2022
Q3
$1K Hold
33
﹤0.01% 2161
2022
Q2
$1K Hold
33
﹤0.01% 2207
2022
Q1
$1K Hold
33
﹤0.01% 2151
2021
Q4
$2K Hold
33
﹤0.01% 2124
2021
Q3
$2K Hold
33
﹤0.01% 2179
2021
Q2
$2K Hold
33
﹤0.01% 2091
2021
Q1
$2K Hold
33
﹤0.01% 1894
2020
Q4
$1K Hold
33
﹤0.01% 1453
2020
Q3
$1K Hold
33
﹤0.01% 1429
2020
Q2
$1K Hold
33
﹤0.01% 1355
2020
Q1
$1K Hold
33
﹤0.01% 1343
2019
Q4
$1K Hold
33
﹤0.01% 1436
2019
Q3
$2K Hold
33
﹤0.01% 1143
2019
Q2
$1K Hold
33
﹤0.01% 1301
2019
Q1
$1K Hold
33
﹤0.01% 1303
2018
Q4
$2K Hold
33
﹤0.01% 1060
2018
Q3
$2K Hold
33
﹤0.01% 1085
2018
Q2
$2K Hold
33
﹤0.01% 1140
2018
Q1
$1K Hold
33
﹤0.01% 1221
2017
Q4
$1K Hold
33
﹤0.01% 1265
2017
Q3
$1K Hold
33
﹤0.01% 1201
2017
Q2
$1K Buy
+33
New +$797 ﹤0.01% 1214

Other funds holding SRDX

TCI Wealth Advisors's SRDX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Surmodics (SRDX) in Q2 2023, closing a stake of 232 shares — an estimated $5.29K sold.

TCI Wealth Advisors first reported a position in SRDX in Q2 2017 and held it in 24 quarters. The position peaked at $5.29K in Q1 2023. 105 funds tracked by Wall St. Rank hold SRDX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Surmodics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 232 Surmodics shares in Q2 2023, an estimated $5.29K.
  • TCI Wealth Advisors first reported a position in Surmodics in Q2 2017 and held it in 24 quarters.
  • TCI Wealth Advisors's Surmodics position peaked at $5.29K in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Surmodics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.